Lantheus Holdings(LNTH)
搜索文档
LNTH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Globenewswire· 2025-09-24 11:15
SAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”), have until Monday, November 10, 2025 to seek appointment as lead plaintiff of the Lantheus class action lawsuit. Captioned Margolis v. Lantheus Holdings, Inc., No. 25-cv-07491 (S.D.N.Y.), the Lantheus class action lawsuit charges Lantheus and certain of Lantheus’ ...
Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan
Globenewswire· 2025-09-24 05:00
BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) and GE HealthCare (NASDAQ: GEHC) today announced an exclusive licensing agreement for GE HealthCare to develop, manufacture, and commercialize Lantheus’ piflufolastat F18 (PYLARIFY® in U.S. market) in Japan for prostate cancer diagnostics and companion diagnostic use. PYLARIFY is used for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in me ...
Lantheus Holdings, Inc. (LNTH) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Prnewswire· 2025-09-23 22:11
Accessibility StatementSkip Navigation BENSALEM, Pa., Sept. 23, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ:Â LNTH). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LANTHEUS HOLDINGS, INC. (LNTH), CONTACT THE LAW OFFICES OF HOWARD G. SMITHÂ BEFORE NOVEMBER 10, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ON ...
Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LNTH
Businesswire· 2025-09-23 14:10
LOS ANGELES--(BUSINESS WIRE)--Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LNTH. ...
Investors who lost money on Lantheus Holdings, Inc. (LNTH) should contact Levi & Korsinsky about pending Class Action - LNTH
Globenewswire· 2025-09-22 19:53
NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lantheus investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/lantheus-holding ...
LNTH INVESTOR DEADLINE: Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Prnewswire· 2025-09-22 15:05
SAN DIEGO , Sept. 22, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, all dates inclusive (the "Class Period"), have until November 10, 2025 to seek appointment as lead plaintiff of the Lantheus class action lawsuit. ...
Lantheus Holdings, Inc. Class Action: The Gross Law Firm Reminds Lantheus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 10, 2025 - LNTH
Prnewswire· 2025-09-22 12:45
NEW YORK , Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH). ...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lantheus Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LNTH
Globenewswire· 2025-09-21 22:54
NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important November 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Lantheus securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr ...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
Globenewswire· 2025-09-21 12:47
公司财务表现 - 公司第一季度业绩低于市场预期 Pylarify表现尤其未达预期 [7] - 公司2025年8月6日再次公布令人失望的业绩 大幅下调Pylarify增长预期 [7] - Pylarify年同比下降8.3% 公司削减2025财年增长预测 [7] 公司股价变动 - 公司普通股股价从2025年8月5日收盘价每股72.83美元 暴跌至2025年8月6日每股51.87美元 [8] - 公司股价单日跌幅约28.8% [8] 公司信息披露问题 - 公司被指控向投资者提供关于Pylarify竞争地位的误导性陈述 [6] - 公司未能恰当评估Pylarify定价和竞争动态 危及产品价格点、收入和整体增长潜力 [6] - 这些陈述导致投资者以人为抬高价格购买公司证券 [6] 公司竞争环境 - 公司将损失归因于持续竞争 影响Pylarify定价动态 [7] - 投资者于2025年5月7日开始质疑公司公开陈述真实性 [7]
Did you lose money in LNTH? Shareholders Who Incurred Significant Losses in Lantheus Holdings, Inc. Should Contact Robbins LLP for Information
Prnewswire· 2025-09-19 22:33
核心诉讼事件 - 律师事务所Robbins LLP代表在2025年2月26日至8月5日期间购买Lantheus Holdings Inc (NASDAQ: LNTH)证券的投资者提起集体诉讼 [1] - 公司被指控在Pylarify产品的竞争地位和定价动态方面发布 materially false and misleading statements [2] - 公司2025年初的提价决策（尽管此前存在价格侵蚀）为竞争对手创造了定价优势 直接危及Pylarify的价格定位、收入和增长潜力 [2] 产品与市场表现 - Lantheus核心放射性药物肿瘤产品Pylarify是一种用于诊断和治疗前列腺癌的PET显像剂 [1] - 2025年8月6日公司公告Pylarify年同比下降8.3% 并大幅下调2025财年增长预期 [4] - 公司将业绩下滑归因于持续的市场竞争对Pylarify定价动态的影响 [4] 股价影响 - 负面公告导致公司普通股股价从2025年8月5日的72.83美元/股暴跌至8月6日的51.87美元/股 [4] - 单日股价跌幅达28.8% 市值出现重大蒸发 [4] 公司治理与诉讼程序 - 指控称公司缺乏对Pylarify市场定价和竞争动态的准确评估能力 [2][3] - 股东需在2025年11月10日前申请作为首席原告代表集体参与诉讼 [4] - 律师事务所采用风险代理收费模式 股东无需预先支付费用 [5]